MAPK4 promotes the proliferation of colon cancer,10 lung cancer,10 prostate cancer,11 and triple‐negative breast cancer12 and reduces tumor sensitivity to inhibitors of ADP‐ribose polymerase in cervical cancer cells13 and PI3K in triple‐negative breast cancer.12 This evidence concerns the gene MAPK4 and neoplasm.